| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.3 |